TWST vs MOH
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
TWST · Twist Bioscience$103.32 ▼ 7.44%
MOH · Molina Healthcare$198.39 ▼ 2.43%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- TWST +252.3%
- MOH +36.5%
Head to head
| Metric | TWST | MOH |
|---|---|---|
| Price | $103.32 | $198.39 |
| Change today | ▼ 7.44% | ▼ 2.43% |
| Market cap | $6.85B | $10.36B |
| Return, 3 months | -26.6% | -0.1% |
| Return, year to date | +225.7% | +14.3% |
| Return, 1 year | +261.8% | +40.1% |
| P/E (TTM) | – | – |
| P/B | 7.7 | 2.5 |
| P/E percentile vs own 5y | 10th | 0th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | +27.9% | -3.4% |
| Net profit growth (YoY) | +24.0% | -51.9% |
| Gross margin | 52.4% | 8.0% |
| Operating margin | -28.8% | 0.6% |
| Net margin | -28.3% | -0.1% |
| Return on equity | -19.1% | -1.2% |
| Analyst target vs. price | +26.1% | +14.9% |
| Analyst buy share | 75% | 29% |
| RSI (14) | 37 | 44 |
| 30-day volatility | 117.4% | 59.4% |
| Max drawdown, 1 year | -49.6% | -39.2% |
| Trend read | Leaning bearish | Leaning bearish |
| Analyst consensus | Buy | Hold |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- MOH is the largest of the group by market value.
- TWST has returned the most over the past year.
- TWST is growing revenue fastest.
- MOH keeps the most profit per dollar of sales.
- MOH has been the calmest stock over the last 30 days.